About the Authors

Walid Nachar

Affiliation Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada

David Busseuil

Affiliation Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada

Yanfen Shi

Affiliation Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada

Teodora Mihalache-Avram

Affiliation Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada

Mélanie Mecteau

Affiliation Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada

Eric Rhéaume

Affiliations Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada

Jean-Claude Tardif

jean-claude.tardif@icm-mhi.org

Affiliations Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada

Competing Interests

The authors have the following interests: The following patents on the theme of HDL and both aortic valve stenosis and diastolic dysfunction were submitted by the Montreal Heart Institute and Drs. Tardif, Rhéaume and Busseuil are mentioned as authors. WO/2010/083611A1 “Method for the prevention and treatment of diastolic dysfunction employing an apolipoproteinA1 (APOA1) mimetic peptide/phospholipid complex”. US20130197226 /Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex”. US20090186808 “Method and compound for the treatment of valvular disease”. These patents do not cover the development of a diastolic dysfunction in a rabbit model, nor the use or selection of housekeeping genes. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: WN DB ER JCT. Performed the experiments: WN DB YS TMA MM. Analyzed the data: WN DB YS ER JCT. Contributed reagents/materials/analysis tools: JCT. Wrote the paper: WN DB ER JCT.